Inventor
MICHAEL HEDVAT
Inventor
US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C12NMicroorganisms or enzymes15%
PatentTitleYear
12,404,329Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3202512,378,326Anti-CD28 x anti-PSMA antibodies202512,365,743Anti-CD28 x anti-PSMA antibodies202512,152,076Bispecific and monospecific antibodies using novel anti-PD-1 sequences202412,006,345Untargeted and targeted IL-10 Fc-fusion proteins202411,932,675PD-1 targeted IL-15/IL-15Ra Fc fusion proteins with improved properties202411,919,956Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3202411,919,958Anti-CD28 compositions202411,851,466Targeted IL-12 heterodimeric Fc-fusion proteins202311,591,401Anti-CD28 compositions202311,492,407Bispecific checkpoint inhibitor antibodies202211,377,477PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof202211,312,770Bispecific and monospecific antibodies using novel anti-PD-1 sequences202211,236,170Bispecific checkpoint inhibitor antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to XENCOR INC (14)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to GENENTECH INC (1)· patent assignee history
2025Patents assigned to JANSSEN BIOTECH INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XENCOR INC | 14 | 2022–2025 |
| JANSSEN BIOTECH INC | 2 | 2025 |
| GENENTECH INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 14 | 2022–2025 |